IMA

ImageneBio, Inc.

IMA.US inmagenebio.com + Research + Basket
Employees 18
Phone 858 345 6265
Fiscal year end December
IPO Mar 26, 2021
Address 12526 High Bluff Drive, San Diego, CA, United States, 92130
4.10
+0.08 (+1.99%)
USD · NASDAQ
52-week range
3.88
8.84
Trading at 4% of the 52-week range
Market Cap
45.72M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
12.60
Div. Yield
N/A
% Institutions
54.49%
% Insiders
16.19%

1 Year

-50.2%

3 Year

-91.4%

10 Year

-98.9%
Description

ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, a non-depleting anti-OX40 monoclonal antibody that binds to OX40 receptor on activated T cells to block receptor binding to OX40 ligand which is in Phase 1b/2a clinical trial. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.

Actions

Add an action for IMA.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Dr. Kristin Yarema Ph.D. CEO & Director 1971
Ms. Yanina Grant-Huerta CFO, Principal Financial Officer & Principal Accounting Officer 1977
Dr. Kurinji Pandiyan Ph.D. Chief Strategy & Operations Officer NA
Ms. Renuka Sivendran Ph.D. Chief Technical Officer NA
Mr. Matt Robbins J.D. General Counsel NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Dec 24, 2025 Joseph P Slattery N/A Purchase 16.00K $5.99 $95.84K SEC
Jul 25, 2025 David P Bonita N/A Purchase 83.61K $29.90 $2.50M SEC
Jul 25, 2025 Otello Stampacchia N/A Purchase 267.56K $29.90 $8.00M SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Bvf Inc 1.11M Jun 30, 2026 9.84% $0.17 0.00%
Blue Owl Capital Holdings LP 917.69K Jun 30, 2026 8.14% $0.81 -4.34%
Orbimed Advisors LLC 909.27K Jun 30, 2026 8.06% $0.10 140.19%
Cable Car Capital LLC 781.60K Jun 30, 2026 6.93% $0.10 3.56%
Omega Fund Management LLC 455.36K Jun 30, 2026 4.04% $1.45 0.00%
RTW INVESTMENTS, LLC 334.45K Jun 30, 2026 2.97% $0.02 0.00%
Vanguard Capital Management, LLC 320.52K Jun 30, 2026 2.84% $0.00 -1.43%
Trails Edge Capital Partners, LP 282.00K Jun 30, 2026 2.50% $0.26 0.00%
BML Capital Management LLC 200.73K Jun 30, 2026 1.78% $0.67 0.00%
Monashee Investment Management LLC 192.34K Jun 30, 2026 1.71% $1.90 0.00%
BlackRock Inc 135.09K Jun 30, 2026 1.20% $0.00 4.55%
Renaissance Technologies Corp 86.93K Jun 30, 2026 0.77% $0.00 6.41%
Adage Capital Partners Gp LLC 66.67K Jun 30, 2026 0.59% $0.00 0.00%
Citadel Advisors Llc 55.61K Jun 30, 2026 0.49% $0.00 -55.28%
Geode Capital Management, LLC 53.51K Jun 30, 2026 0.47% $0.00 -10.71%
NEA Management Company, LLC 50.01K Jun 30, 2026 0.44% $0.02 0.00%
NANO CAP NEW MILLENNIUM GROWTH FUND L P 50.00K Jun 30, 2026 0.44% $0.23 66.67%
HSBC Holdings PLC 34.23K Jun 30, 2026 0.30% $0.00 -1.88%
Sofinnova Ventures 31.88K Jun 30, 2026 0.28% $0.01 0.00%
Vanguard Fiduciary Trust Co 27.48K Jun 30, 2026 0.24% $0.00 0.69%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 264.77K 2.35% ▲ 0.00% Sep 30, 2026
2 Worldwide Healthcare Ord 135.52K 1.20% ▲ 0.00% Jul 31, 2026
3 Fidelity Extended Market Index 25.83K 0.23% ▼ 0.54% Aug 31, 2026
4 iShares Micro-Cap ETF 24.24K 0.21% ▲ 0.00% Oct 29, 2026
5 Fidelity Series Total Market Index 7.30K 0.06% ▲ 0.00% Aug 31, 2026
6 Fidelity Total Market Index 5.82K 0.05% ▲ 0.00% Aug 31, 2026
7 Fidelity Nasdaq Composite Index 3.39K 0.03% ▲ 0.00% Aug 31, 2026
8 Vanguard Balanced Index Inv 3.28K 0.03% ▲ 0.00% Sep 30, 2026
9 1290 VT Micro Cap K 1.79K 0.02% ▲ 0.00% Aug 31, 2026
10 Vanguard U.S. Eq Idx £ Acc 602.00 0.01% ▲ 0.00% Sep 30, 2026

Financial Highlights

▼
Market Cap: $45.72M
EBITDA: $-58.37M
Book Value: $12.60
Earnings/Share: $-4.09
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -43.06%
ROE (TTM): -82.68%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Valuation Metrics

Enterprise Value: $-87.81M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 11.37M
Shares Float: 5.83M
% Insiders: 16.19%
% Institutions: 54.49%
Shares Short: 61.35K
Shares Short (Prior Month): 32.85K
Short Ratio: 3.80
Short % Float: 0.55%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$800.00K
Cost of Goods Sold
adjust
$-1.03M
Gross Profit
subtotal
$-233.00K
SG&A
adjust
$-20.73M
R&D
adjust
$-28.53M
Operating Income
subtotal
$-48.45M
Other / Non-Operating Items
adjust
$3.10M
Net Income
subtotal
$-45.35M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about IMA.US!